开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2024-08-12 ms4000000683968805 来自湖南省

审稿速度:3.0 | 投稿命中率:95.0
经验分享：可以

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2023-04-28 ms1000000619009997 来自湖北省

偏重的研究方向：QJM
经验分享：这个杂志影响因子这么高，为啥中科院分区这么低

90 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2023-08-14 翊翊翊来自山东省

能投生信类文章吗？

110 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2023-05-16 ms3000001779537693 来自北京

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：内科
经验分享：很难投中

97 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2023-01-10 ms7000001910214771 来自辽宁省

想问一下大家，病例awaiting reviewer selection需要多久才能送审啊

90 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2022-06-03 ms7000001370020190

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：耳鼻喉;案例报告
经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦

96 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2020-02-28 molly12345

审稿速度:1.0
经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受

232 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2018-05-25 qiangq

审稿速度:1.0 | 投稿命中率:25.0
经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。

339 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2022-10-25 ms9000000375851820

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：不清楚
经验分享：心内文章，20小时内秒拒，没有原因

82 0

[GetPortalCommentsPageByObjectIdResponse(id=2219656, encodeId=0da8221965632, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ac06559858, createdName=ms4000000683968805, createdTime=Mon Aug 12 00:35:42 CST 2024, time=2024-08-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向：QJM 经验分享：这个杂志影响因子这么高，为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：内科 经验分享：很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家，病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：耳鼻喉;案例报告 经验分享：投的是案例报告，5月31号投稿，6月1号编辑回信建议删图，当天删图后再提交，6月2号immediately accepted，虽然只是案例报告，但是我第一篇接收的，科研小菜鸟很开心，对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0 经验分享：case report~2月21号投稿，24号编辑回信建议修改格式，24号按要求改格式、删图，25号编辑审稿后直接修回，26号修后再投，27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：在第一篇肺癌的基础上，我又投了一篇个案报道，脂肪平滑肌肉瘤，更是荣幸地immediately accepted，导致我现在很喜欢这个杂志，原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：不清楚 经验分享：心内文章，20小时内秒拒，没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2022-10-19 ms5000001621098193

这杂志怎么突然涨分那么多？？？？

96 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务